Marker Therapeutics Inc — Stato Patrimoniale (NASDAQ:MRKR) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 45.61 M68.14 M34.42 M17.13 M22.02 M19.07 M Totale passività 18.27 M24.15 M14.82 M3.07 M3.46 M2.27 M Patrimonio netto totale 27.34 M43.99 M19.6 M14.05 M18.56 M16.8 M Totale passività e patrimonio netto 45.61 M68.14 M34.42 M17.13 M22.02 M19.07 M Debito totale —————— Indebitamento netto ——————

Notizie

H.C. Wainwright conferma il rating Buy su Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

Marker Therapeutics fissa la data per l’assemblea annuale degli azionisti 2026

Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?

5 Small Drug Stocks to Buy as Industry Recovery Picks Up

Marker Therapeutics mantiene il rating Buy da H.C. Wainwright

Marker Therapeutics stock maintains Buy rating at H.C. Wainwright

Brookline Capital alza il target di prezzo delle azioni Marker Therapeutics a $5,60